# Emergent Manufacturing Operations Baltimore LLC

Canonical: https://abierto.us/vendors/emergent-manufacturing-operations-baltimore-llc-n9dcuhyeun26

- UEI: N9DCUHYEUN26
- CAGE: 6EBP9
- Location: Baltimore, MD
- Awards in window: 4 (4 transactions), -$23,711,095 obligated, July 5, 2024 to July 10, 2025

## Awarding agencies

- Office of Assistant Secretary for Preparedness and Response: 4 awards, -$23,711,095

## Industries

- 325412 Pharmaceutical Preparation Manufacturing: $0
- 236210 Industrial Building Construction: -$23,711,095

## Competition

- Full and Open Competition: 4 awards

## Largest awards

- HHSO10033001T (delivery order): $0, Barda - Aspr / Daappo / Barda DCMA. The Purpose of This Modification Is To: - Close This Purchase Order Contract in Line with FAR 4.804. https://www.usaspending.gov/award/CONT_AWD_HHSO10033001T_7505_HHSO100201300008I_7505/
- 75A50120F33006 (delivery order): -$0, Barda - Aspr / Daappo / Barda DCMA. The Purpose of This Bilateral Modification Is to Deobligate $0.32 in Unexpended Funds from Clin 001.. https://www.usaspending.gov/award/CONT_AWD_75A50120F33006_7505_HHSO100201200004I_7505/
- 75A50119F33005 (delivery order): -$1,618,700, Barda - Aspr / Daappo / Barda DCMA. The Purpose of This Bilateral Modification Is to Deobligate $1,618,699.68 in Unexpended Funds from Clins 001, 012, 013, and 014.. https://www.usaspending.gov/award/CONT_AWD_75A50119F33005_7505_HHSO100201200004I_7505/
- HHSO100201200004I: -$22,092,395, Barda - Aspr / Daappo / Barda DCMA. The Purpose of This Bilateral Modification Is to Deobligate $19,718,904 from Clin 001 and $2,373,491.20 from Clin 002, for a Total Deobligated Amount of $22,092,395.20 in Unexpended Funds.. https://www.usaspending.gov/award/CONT_IDV_HHSO100201200004I_7505/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/emergent-manufacturing-operations-baltimore-llc-n9dcuhyeun26.